468 related articles for article (PubMed ID: 26851562)
41. A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan.
Tsutani K; Igarashi A; Fujikawa K; Evers T; Kubin M; Lamotte M; Annemans L
Intern Med; 2007; 46(4):157-62. PubMed ID: 17301509
[TBL] [Abstract][Full Text] [Related]
42. Study design of ASPirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial.
ASPREE Investigator Group
Contemp Clin Trials; 2013 Nov; 36(2):555-64. PubMed ID: 24113028
[TBL] [Abstract][Full Text] [Related]
43. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk.
Goldstein JL; Whellan DJ; Scheiman JM; Cryer BL; Eisen GM; Lanas A; Fort JG
Cardiovasc Ther; 2016 Apr; 34(2):59-66. PubMed ID: 26725920
[TBL] [Abstract][Full Text] [Related]
44. Review article: gastrointestinal bleeding with low-dose aspirin - what's the risk?
Laine L
Aliment Pharmacol Ther; 2006 Sep; 24(6):897-908. PubMed ID: 16948802
[TBL] [Abstract][Full Text] [Related]
45. On the potential contribution of aspirin to healthy ageing programmes.
Morgan GP
Age Ageing; 2016 Mar; 45(2):e1-3. PubMed ID: 22101149
[No Abstract] [Full Text] [Related]
46. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?
Mutter J; Grandy R; Hulkower S; Stigleman S
J Fam Pract; 2018 Apr; 67(4):247-248. PubMed ID: 29614147
[TBL] [Abstract][Full Text] [Related]
47. Aspirin for primary prevention of cardiovascular disease events.
Nemerovski CW; Salinitri FD; Morbitzer KA; Moser LR
Pharmacotherapy; 2012 Nov; 32(11):1020-35. PubMed ID: 23019080
[TBL] [Abstract][Full Text] [Related]
48. Aspirin for primary prevention of cardiovascular disease in women.
Jneid H
Methodist Debakey Cardiovasc J; 2010 Nov-2011 Jan; 6(4):37-42. PubMed ID: 21088658
[TBL] [Abstract][Full Text] [Related]
49. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
50. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
Leggio M; Bendini MG; Caldarone E; Lombardi M; Severi P; D'Emidio S; Stavri DC; Armeni M; Bravi V; Mazza A
Diabetes Metab; 2018 Jun; 44(3):217-225. PubMed ID: 29257747
[TBL] [Abstract][Full Text] [Related]
51. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
Dehmer SP; O'Keefe LR; Evans CV; Guirguis-Blake JM; Perdue LA; Maciosek MV
JAMA; 2022 Apr; 327(16):1598-1607. PubMed ID: 35471506
[TBL] [Abstract][Full Text] [Related]
52. Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force.
Hayden M; Pignone M; Phillips C; Mulrow C
Ann Intern Med; 2002 Jan; 136(2):161-72. PubMed ID: 11790072
[TBL] [Abstract][Full Text] [Related]
53. Aspirin in the Prevention of Cardiovascular Disease and Cancer.
Ricciotti E; FitzGerald GA
Annu Rev Med; 2021 Jan; 72():473-495. PubMed ID: 33502899
[TBL] [Abstract][Full Text] [Related]
54. Reinitiating aspirin therapy for primary prevention of cardiovascular events in a patient post-aspirin-induced upper gastrointestinal bleed: a case report and review of literature.
Adly G; Plakogiannis R
Ann Pharmacother; 2013 Feb; 47(2):e8. PubMed ID: 23386069
[TBL] [Abstract][Full Text] [Related]
55. Aspirin for primary prevention: USPSTF recommendations for CVD and colorectal cancer.
Smith DK; Demetriou T; Weber C
J Fam Pract; 2019 Apr; 68(3):146-151. PubMed ID: 31039213
[TBL] [Abstract][Full Text] [Related]
56. Are the current recommendations for the use of aspirin in primary prevention of cardiovascular disease applicable in low-income countries?
Noubiap JJ; Nansseu JR
Vasc Health Risk Manag; 2015; 11():503-6. PubMed ID: 26345154
[TBL] [Abstract][Full Text] [Related]
57. Aspirin for primary prevention: yes or no?
Selak V; Elley CR; Wells S; Rodgers A; Sharpe N
J Prim Health Care; 2010 Jun; 2(2):92-9. PubMed ID: 20690297
[TBL] [Abstract][Full Text] [Related]
58. Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis.
Stavrakis S; Stoner JA; Azar M; Wayangankar S; Thadani U
Am J Med Sci; 2011 Jan; 341(1):1-9. PubMed ID: 21191260
[TBL] [Abstract][Full Text] [Related]
59. Primary and secondary prevention of cardiovascular disease in diabetes with aspirin.
Schnell O; Erbach M; Hummel M
Diab Vasc Dis Res; 2012 Oct; 9(4):245-55. PubMed ID: 22508698
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]